US EditionNeurocrine Biosciences to Present at Upcoming Investor Conferences in March
Neurocrine Biosciences management will engage investors at the TD Cowen Health Care Conference to discuss company plans and future performance forecasts.
- February 24, 2026, Neurocrine Biosciences, Inc. announced management will participate at upcoming investor conferences, according to a SAN DIEGO release.
- Company representatives said presentations may include forward-looking statements about plans and financial guidance, which can be identified by words like `expect`, `plan` and `guidance`.
- Neurocrine named the TD Cowen 46th Annual Health Care Conference as a forum where management team members will present.
- The company cautioned that forward‑looking statements are subject to substantial risks and uncertainties and assumes no obligation to update them after they are made.
- Late‑February distribution via ACCESS Newswire and PRNewswire ensured broad public dissemination of the notice to investor audiences on Feb. 24, 2026 and February 25, 2026.
27 Articles
27 Articles
Armanino Foods to Participate in Upcoming Investor Conferences
PLEASANTON, CA / ACCESS Newswire / February 25, 2026 / Armanino Foods of Distinction, Inc. (OTCQX:AMNF), a leading provider of pesto and specialty frozen foods for North American foodservice, retail, and industrial customers, today announced that management will participate in…
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
NAARDEN, the Netherlands and MIAMI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with…
The Record
Teva to Present at the Upcoming Investor Conferences in March
PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate in the upcoming investor conferences in March as follows:
Coverage Details
Bias Distribution
- 56% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
